UBS Downgrades InterMune To Neutral
August 28, 2014 at 10:43 AM EDT
Analysts at UBS downgraded InterMune (NASDAQ: ITMN) from Buy to Neutral. The price target for InterMune has been raised from $52.00 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.